MNA, bought at 135 to 145 and now at 229, is doing really well, and the move into healthcare is just getting started; its nearest catalyst is an October 24 presentation updating phase 3 data for its cancer therapy, with earnings November 6.

One of the buys that we made in the uh alpha membership is Mona. Uh and we bought this right here once the like 190 enthus enthusiasm faded. We bought this right around here like 135 to 145 in this region.

Uh it's now sitting at 229. So this is this is one that's doing really fantastically. Not everything does perfectly. But I will say it's it's been uh it's the the move to healthcare I think is just getting started too. So I'll be transparent about that.

when are Moerna earnings? Mona earnings are coming up on November 6th. Let me see if there's anything lately on Mona.

So, what I want to see is anything on Mona. I'm just trying to pull up Mona.

The next sector for artificial intelligence might be hiding in plain sight. and we should talk about some of the breakthroughs that are going on as well as something happening this Saturday that could be another catalyst for a particular stock that's been doing pretty well.

What we're talking about in this is everything to do with how AI is affecting already and going to affect healthc care stocks. Some of the stocks we'll touch on here are going to be Tempest AI, Mona, and Eli Liy.

Now, I want to be clear out of these three, I've got exposure to two of them. So the first thing to know is that Merna has a meeting coming up this Saturday. Uh it is going to be a presentation.

They purposefully do it when the market is closed. Is going to be a presentation on October 24th. It's the nearest catalyst and it is an update on phase 3 data for their cancer therapy which is the